Browsing by Author Castiglione-Gertsch, Monica

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 41  next >
Issue DateTitleAuthor(s)Citation
2003Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trialCoates, Alan; Bonetti, Marco; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Nasi, M. Laura; O'Neill, Anne; Price, Karen N.; School of Public Health: Public HealthAdjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trial, Journal of the National Cancer Institute, vol.95,(24),2003,pp 1833-1846
2003Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVCoates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Lindtner, Jurji; Price, Karen N.; Rudenstam, Carl-Magnus; Senn, Hans-Jorg; School of Public Health: Public HealthAdjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV, Journal of Clinical Oncology, vol.21,(24),2003,pp 4517-4523
2008Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trialCoates, Alan; Altermatt, Hans J; Braye, Stephen; Castiglione-Gertsch, Monica; Del Curto, Barbara; Dell'Orto, Patrizia; Gelber, Richard D. (Prof); Goldhirsch, A; Gusterson, Barry; Henriksen, Katrine L; Lacroix-Triki, Magali; Lykkesfeldt, Anne E; Mastropasqua, Mauro G.; Mery, Eliane; Price, K. N.; Rasmussen, Brigitte B; Regan, Meredith M.; Thurlimann, Beat; Viale, Giuseppe; School of Public Health: Public HealthAdjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial, The Lancet, vol.9, N/A, 2008,pp 23-28
2001Adjuvant therapy for very young women with breast cancer: need for tailored treatments.Coates, Alan; Bryant,, J; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); Gray, R; Green, S; Yothers, G; School of Public Health: Public HealthAdjuvant therapy for very young women with breast cancer: need for tailored treatments., Journal of the National Cancer Institute, vol.30,(N/A),2001,pp 44-51
2010Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et al, various; Giobbie-Hurder, Anita; Gusterson,, B; Maiorano, Eugenio; Mallon, Elizabeth; Mastropasqua, Mauro G.; Sonzogni, A; Viale, Giuseppe; School of Public Health: Public HealthAdverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer., Annals of Oncology, vol.21, 2,pp 245-254
2016Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to VCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Forbes, John F.; Gelber, Richard; Gianni, Lorenzo; Goldhirsch, Aron; Karlsson, Per; Price, Karen; Sun, Zhuoxin; Thurlimann, B.; School of Public Health: Public HealthAnnual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V, Journal of Clinical Oncology, vol.34, 9, 2016,pp 927-935
2004Body Mass Index As A Prognostic Feature In Operable Breast Cancer: The International Breast Cancer Study Group Experience.Coates, Alan; Berclaz, G; Castiglione-Gertsch, Monica; Collins, John; Erzen, Darja; et, al; Holmberg, Stig B.; Li, S; Lindtner, Jurii; Price, K N; Rudenstam, Carl-Magnus; School of Public Health: Public HealthBody Mass Index As A Prognostic Feature In Operable Breast Cancer: The International Breast Cancer Study Group Experience., Annals of Oncology 2005, vol.15,(6),2004,pp 875-884
2009Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trialCoates, Alan; Campone, N; Castiglione-Gertsch, Monica; Forbes, John; Hawle, H; Mouridsen, Henning; Paridaens, R.J.; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthBone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial, Annals of Oncology, vol.20, 9,pp 1489-1498
2007Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; et, al; Forbes, John F.; Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthCardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(36),2007,pp 5715-5722
2008Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study GroupCoates, Alan; Braye, Stephen; Brown, Robert; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Gusterson, Barry A.; Kovacs, Aniko; Maiorano, Eugenio; Mastropasqua, Mauro G.; Ohlschlegel, Christian; Perin, Tiziana; Pillay, Komala; Price, Karen N.; Regan, Meredith M.; Rusca, Tiziana; Viale, Giuseppe; School of Public Health: Public HealthChemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors-International Breast Cancer Study Group, Journal of Clinical Oncology, vol.26, 9, 2008,pp 1404-1410
2005A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; et, al; Forbes, John F.; Gelber, Richard D. (Prof); Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Rabaglio, Manuela; Thurlimann, Beat; School of Public Health: Public HealthA comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer., New England Journal of Medicine, vol.353,(26),2005,pp 2747-2757
2003Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node statusCoates, Alan; Byrne, Michael J.; Castiglione-Gertsch, Monica; Collins, John; Cortes-Funes, Hernan; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Golouh, Rastko; Grigolato, Piergioranni; Lindtner, Jurii; Litman, H; Maffini, Fausto; Martinez-Tello, Francisco J.; Masullo, Michele; Price, Karen; Simoncini, Edda; Spataro, Vito J.; Viale, Giuseppe; School of Public Health: Public HealthDecreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status, Cancer, vol.97,(7),2003,pp 1591-1600
2008Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical TrialsCoates, Alan; Castiglione-Gertsch, Monica; Gelber, Richard D. (Prof); Goldhirsch, Aron; Gusterson, Barry A.; Holmberg, Stig B.; Lindtner, Jurii; Mallon, Elizabeth; Murray, E.; Pestalozzi, B. C.; Price, Karen N.; Snyder, Raymond; Thurlimann, Beat; Viale, Giuseppe; Zahrieh, David; School of Public Health: Public HealthDistinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials, Journal of Clinical Oncology, vol.26, 18, 2008,pp 3006-3014
2002Duration of Adjuvant Chemotherapy for Breast Cancer: A Joint Analysis of Two Randomised Trials Investigating Three Versus Six Courses of CMFCoates, Alan; Bastert, G; Bonetti, M; Castiglione-Gertsch, Monica; Colleoni, Marco; et, al; Gelber, Richard D. (Prof); Litman, H; Rudenstam, Carl-Magnus; Sauerbrei, W; Schumacher, M; School of Public Health: Public HealthDuration of Adjuvant Chemotherapy for Breast Cancer: A Joint Analysis of Two Randomised Trials Investigating Three Versus Six Courses of CMF, British Journal of Cancer, vol.86,(N/A),2002,pp 1705-1714
2007Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); International, B e; Pagani, O.; Price, Karen N.; Simoncini, Edda; School of Public Health: Public HealthEffects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Annals of Oncology 2005, vol.18,(7),2007,pp 1177-1184
2002Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trialCoates, Alan; Bernhard, J; Bonetti,, M; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Hirsch, D; Nasi,, M; Price, Aaron; Zahrieh, D; School of Public Health: Public HealthEndocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial, Journal of the National Cancer Institute, vol.94,(14),2002,pp 1054-1065
2008Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerCoates, Alan; Castiglione-Gertsch, Monica; Cole, B F; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, A; Golouh, Rastko; Gruber, G; Gusterson, Barry; Holmberg, Stig B.; Lindtner, Jurii; Price, K. N.; Simoncini, Edda; Thurlimann, Beat; School of Public Health: Public HealthExtracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer, Annals of Oncology, vol.19, N/A, 2008,pp 1393-1401
2007Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et, al; Forbes, John F.; Gelber, Richard D. (Prof); Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Thurlimann, Beat; School of Public Health: Public HealthFive years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(5),2007,pp 486-492
2006Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).Coates, Alan; Castiglione-Gertsch, Monica; Collins, John; Crivellari, Diana; Fey, Martin F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Lindtner, Jurii; Murray, E.; Pagani, O.; Pestalozzi, B. C.; Price, K. N.; Simoncini, Edda; Zahrieh, David; School of Public Health: Public HealthIdentifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)., Annals of Oncology 2005, vol.17,(6),2006,pp 935-944
2006Impact of Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients With Lymph Node-Negative Breast Cancer: Results on the Effect of Age From the InternationalCoates, Alan; Aebi, Stefan; Bernhard, Jurg; Castiglione-Gertsch, Monica; Collins, John; et, al; Forbes, J; Gelber, Richard D. (Prof); Hurny, Christoph; Murray, E.; Zahrieh, David; School of Public Health: Public HealthImpact of Adjuvant Chemotherapy Followed By Goserelin Compared With Either Modality Alone on Amenorrhea, Hot Flashes, and Quality of Life in Premenopausal Patients With Lymph Node-Negative Breast Cancer: Results on the Effect of Age From the International, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(3),2006,pp 263-270